Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:Temsirolimus Named CCI-779 162635-04-3,Temsirolimus Called NSC 683864 CAS 162635-04-3,Temsirolimus MTOR Inhibitor CAS 162635-04-3
Conbott Pharmtech Co.,Ltd. Temsirolimus Named CCI-779 162635-04-3,Temsirolimus Called NSC 683864 CAS 162635-04-3,Temsirolimus MTOR Inhibitor CAS 162635-04-3
Home > Products > Inhibitors > MTOR Inhibitor > Anti Angiogenic Temsirolimus(CCI-779, NSC 683864) CAS 162635-04-3
Title
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

Anti Angiogenic Temsirolimus(CCI-779, NSC 683864) CAS 162635-04-3

Share to:  
    Min. Order: 1 Gram
    Delivery Time: 10 Days

Basic Info

Model No.: 162635-04-3

Additional Info

Packaging: As required

Productivity: Customized

Brand: Conbottpharm

Transportation: Air

Place of Origin: China

Supply Ability: Commercial

Certificate: Documents Support

Product Description

Over the years of experience in the industry, we are engaged in offering a rang of high quality Temsirolimus (CCI-779) CAS 162635-04-3. The alternative name of it can called CCI-779, sirolimus, NSC 683864 and Torisel which is a derivative and prodrug of rapamycin, a specific MTOR Inhibitor, and widely used in treating renal cell carcinoma (RCC). We used valuable raw material and adopt advanced technology to ensure its high purity and flawless quality. The Temsirolimus CAS NO 162635-04-3 have been commercialization productive. We keep certain inventory to meet clients requirement.

Thera. Category: Anti angiogenic

Cas No.: 162635-04-3

Synonym: TEMSIROLIMUS;CCL-779;Rapamycin 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate;42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin;C15182;TeMsiroliMus (CCI-779, Torisel);rapaMycin 42-ester with 3-hydroxy-2-(hydroxyMethyl)-2-Methylpropionic acid;TeMsiroliMus (Torisel)

Temsirolimus 162635-04-3

Molecular Formula: C56H87NO16

Molecular Weight: 1030.29

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage:Temsirolimus (CCI-779) is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in late May 2007,[2] and was also approved by the European Medicines Agency (EMEA) on November 2007. It is a derivative and prodrug of sirolimus.

Looking for ideal Temsirolimus Named CCI-779 162635-04-3 Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Temsirolimus Called NSC 683864 CAS 162635-04-3 are quality guaranteed. We are China Origin Factory of Temsirolimus Mtor Inhibitor CAS 162635-04-3. If you have any question, please feel free to contact us.

Product Categories : Inhibitors > MTOR Inhibitor

Product Images
  • Anti Angiogenic Temsirolimus(CCI-779, NSC 683864) CAS 162635-04-3
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2019 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?